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Methods and Myopia?  Some Praise, and Problem and a Plea 
 
J Ives 
 
In their paper, Mathews et al aim to “begin an important discussion” about how to 
measure success in Bioethics, and in doing so they set out a typology of bioethics 
research and scholarship with the arguably correct assumption that we cannot 
evaluate success in Bioethics without first understanding what its goals are.  
 
The authors make a sound case for the need to pay attention to measures of success 
in Bioethics, noting the substantial pressures on researchers from funders and 
research institutions to “demonstrate and forecast the value and impact” of 
research.  It does seem likely that ‘success’ is likely to hinge on successful translation 
into practice.  As Cribb noted in 2010: 
 
“this idea somehow sustains a great deal of work in applied ethics, 
including medical ethics. That is, while there are some scholars in applied 
ethics who would wish to stress that their focus is specifically on ethical 
theory, and while there are perhaps very few applied ethicists who 
would see practical prescription as intrinsic to their role, nonetheless the 
broader ‘business’ or ‘profession’ of applied ethics is widely 
underpinned, both economically and rhetorically, by a presumption that 
ethical scholarship can somehow or other be cashed out in practice.”1 
Certainly this rings true in the UK.  The Research Excellence Framework (REF)2 - the 
national exercise to measure the quality of research in UK universities - assumes that 
‘Impact’ can be measured and is an important signifier of quality.  This highlights 
further the importance of having some idea of how to model and evaluate successful 
translation of Bioethics scholarship and research.  Given this I am genuinely 
supportive of the exercise, but want to add a critical voice in the form of three 
considerations that I feel ought to be attended to before the work progresses 
further. 
 
1.  A problematic typology 
 
The typology proposed to categorise Bioethics research and scholarship carves 
Bioethics up in two ways. First, it says Bioethics research and scholarship can ask 
either descriptive or prescriptive questions.  Second, it says that both descriptive and 
prescriptive questions can be answered in three ways: conceptually, by consensus or 
engagement, or empirically (but notes that descriptive projects only identify and 
describe issues rather than attempt to resolve them normatively). 
 
There are, to my mind, a few problems with this typology, which I will attempt to 
elucidate briefly and succinctly.  The suggestion that it is possible to separate neatly 
these kinds of research activity is highly problematic.  There is a burgeoning 
literature on ‘Empirical Bioethics’ methodologies that blend empirical and 
conceptual work3-5, and the typology offered appears to ignore this.  Whilst that 
literature is diverse, there is certainly little support for the notion that, for example, 
a prescriptive question can be answered empirically with no corresponding 
conceptual work.  Similarly, that literature is critical of the idea that purely 
conceptual work can have valuable translational impact.  Indeed, one of the key 
drivers for these methodological innovations is the idea that ‘Empirical Bioethics’ is 
oriented towards practice and impact in a way that theoretical/conceptual ethics 
cannot be.  The typology proposed by Mathews et al. fails to acknowledge this kind 
of work.  Consequently the typology, perhaps unintentionally, at worst excludes 
work using these kinds of methodologies from being ‘Bioethics’, and at best renders 
simplistic, and mute, a very complex methodological development. 
 
Connected to the issue above is that whilst the authors of the typology have 
separated consensus and engagement methods from empirical methods, the 
literature I refer to above considers engagement and consensus methods to be 
examples of empirical work.  Indeed it is hard to see how consensus or engagement 
can be undertaken in any way that is not empirical6-7, and so treating them as 
discrete methods is problematic. 
 
 
2: A missing aim of Bioethics scholarship and research 
 
A relatively minor criticism, perhaps, but in discussing the goals of bioethics 
scholarship and research the authors identify a series of proximate project-level and 
broader domain-level goals that are couched distinctly in terms of research projects 
and conceptual development.  In doing so, other important and legitimate goals of 
bioethics scholarship, such as education, facilitating public debate and raising public 
awareness are ignored.  It is important, I suggest, for on-going work of this kind to 
consider educational and public engagement as goals of bioethics scholarship in 
their own right, and how success might be measured in that sphere.  There are 
postgraduate (and undergraduate) programmes in Bioethics in Universities all over 
the world, as well other less formal educational and public engagement forums.   At 
Centre for Medical Ethics at the University of Bristol, UK, my colleagues and I engage 
in a wide range of public engagement activities8-9 that are certainly not captured by 
the typology proposed.  They ask neither prescriptive nor descriptive questions, and 
do not have proximate or domain-level goals; but are nonetheless an integral part of 
our bioethics scholarship.  These activities do not aim to “identify, frame, and solve 
problems in medicine, public health and the biosciences”.   Rather, they aim to 
educate, raise awareness, and facilitate and stimulate thought.   In failing to include 
these kinds of activities, the paper from Mathews et al excludes from Bioethics 
scholarship activities that we, and likely many others, see as being integral to our 
professional roles. 
 
 
3. A general and dangerous myopia? 
 
My final point is a very general one, and risks coming across as more caustic than I 
would want it to – but it still needs making.  Considering the points made above, the 
paper, and the undertaking, may be guilty of what Campbell10 described in 2000 as a 
‘myopia’ in American Bioethics’; which in this case means that the development of 
the typology and the suggested on-going work seems to focus exclusively on 
American practice, but does not limit itself to talking about ‘American’ Bioethics.    
The neatly differentiated methodological typology, for example, might reflect the 
way bioethics is practiced in the US, but appears to ignore the methodologically 
complex innovations that are increasingly prominent in European Bioethics.   The 
reason I suggest that it is dangerous speaks to the reach of American Bioethics and 
its potential power to set agendas internationally that could have consequences for 
the way bioethics is understood, and therefore evaluated, in other jurisdictions. This 
is, of course, going to be problematic for many of those practicing bioethics outside 
of the US. If ‘Bioethics’ is defined by US practice only, and bioethics is nonetheless 
practised worldwide, there is a risk of alienation, schism and fracturing of the field. 
 
4. Conclusion – an appeal 
 
I applaud the aims of this project, and what Matthews et al are attempting is no 
small undertaking.  The very explicit attempt to include a wide range of disciplines, 
approaches and types of question, and to not be exclusive, speaks to the kind of 
Bioethics that I personally want to see.  I do, however, want to make an appeal.  A 
project such as this needs to be very clear about what is doing and for whom – and 
there seem to be two options: 
 
(1) Such work can be explicitly focussed on American Bioethics, but must 
acknowledge that it will consequently be limited in scope and reach, or 
 
(2) Such work can engage with Bioethics more generally and have wider 
reach, but only if it involves a wider range of Bioethics stakeholders and is 
attendant to a wider range of Bioethics practices and literatures. 
 
I would favour the latter, and would therefore urge Mathews et al to continue this 
work, but avoid the risk of myopia by engaging with the international Bioethics 
community as the work progresses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
1.  A Cribb, “Translational ethics? The theory-practice gap in medical ethics”. Journal 
of Medical Ethics 36 (2010): 207-210, at 207 
2.  Higher education Funding Council for England “REF impact” 
http://www.hefce.ac.uk/rsrch/REFimpact/.  Accessed 27th July 2016, 0752 GMT. 
 
3.  P Borry, P Schotsmans P, K Deirickx. 2005.  “The birth of the Empirical Turn in 
Bioethics”.  Bioethics 1, no.1 (2005): 49-71 
 
4.  R Davies, J Ives,  M Dunn. “A Systematic Review of Empirical Bioethics 
Methodologies”.  BMC Medical Ethics 16 (2015) 
 
5. J Ives, M Dunn, A Cribb. “Empirical Bioethics: Practical and Theoretical 
Perspectives” (Cambridge University Press, in press 2016) 
 
6.  S Kim, I Wall, A Stanczyk, R De Vries.  “Assessing the public's views in research 
ethics controversies: deliberative democracy and bioethics as natural allies” Journal 
of Empirical Research on Human Research Ethics 4, no. 4 (2009): 3–16.   
7.  G Widdershoven, T Abma, B Molewijk. “Empirical ethics as dialogical practice” 
Bioethics 23 no. (2009):236–248.   
8.  “Death: Is it your right to chose?”.  
https://www.bristolmuseums.org.uk/blog/exhibitions/death-is-it-your-right-to-
choose/. Accessed 27th July 2016, 12:00 GMT. 
9.  “GW4 Dying well – How do end-of-life decisions happen?” 
https://gw4dyingwell.wordpress.com/projects/gw4-accelerator/.  Accessed 27th July 
2016, 11:59 GMT. 
10.  A. V. Campbell. “”My country ‘tis of thee” - The Myopia of American Bioethics” 
Medicine, Health Care and Philosophy 3, no. 2 (2000): 195-198. 
 
 
 
 
 
